Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- IPro for Lixiana®
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Information for professionals for Lixiana®:
Daiichi Sankyo (Schweiz) AG
Complete information for professionals
DDD
Änderungen anzeigen
Print
Composition.
Galenic Form
Indication.
Usage
Contra Indication
Warning restrictions.
Interactions.
Pregnancy
Driving ability
Unwanted effects
Overdose
Effects
Pharm.kinetik
Preclinical
Other advice
Swissmedic-Nr.
Packages
Registration owner
Last update of information
B01AF03 - Edoxaban
ATC-DDD Version 2016. Source:
WHO
B - Blood and Blood Forming Organs
B01 - Antithrombotic Agents
B01A - Antithrombotic Agents
B01AF - Direct Factor Xa Inhibitors
The DDDs are based on the treatment of patients with NVAF (nonvalvular atrial fibrillation).
B01AF03 - Edoxaban
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
